Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter Progesterone Receptor Antikörper (AA 1-200)

Der Kaninchen Monoklonal anti-Progesterone Receptor Antikörper wird verwendet zum Nachweis von Progesterone Receptor in Proben von Human. Er wurde validiert für IHC.
Produktnummer ABIN7858668
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für Rekombinanter Progesterone Receptor Antikörper (AA 1-200) (ABIN7858668)

Target

Alle Progesterone Receptor (PGR) Antikörper anzeigen
Progesterone Receptor (PGR)

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 247
  • 46
  • 40
  • 16
  • 15
  • 8
  • 7
  • 6
  • 5
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 175
  • 79
Kaninchen

Klonalität

  • 148
  • 105
  • 1
Monoklonal

Konjugat

  • 154
  • 16
  • 11
  • 9
  • 7
  • 6
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser Progesterone Receptor Antikörper ist unkonjugiert

Applikation

  • 196
  • 99
  • 86
  • 43
  • 38
  • 38
  • 32
  • 26
  • 26
  • 22
  • 12
  • 10
  • 7
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Klon

PGR-8099R
  • Bindungsspezifität

    • 16
    • 16
    • 15
    • 15
    • 13
    • 10
    • 10
    • 10
    • 8
    • 8
    • 7
    • 6
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-200

    Verwendungszweck

    Recombinant Progesterone Receptor (Marker of Progestin Dependence) Antibody

    Spezifität

    Progesterone is one of the central regulators of female reproduction. In breast development, progesterone is involved in the formation of lobular-alveolar structures and also affects differentiation in the breast by modulation of milk protein synthesis. The cellular effects of progesterone are mediated through progesterone receptors (PR). PR, a protein with 946 amino acids, is a ligand-activated transcription factor member of the steroid receptor super family of nuclear receptors. PR is predominantly expressed in female sex steroid responsive tissues such as the mammary gland, uterus and ovary but is also found in other tissues such as endocrine cells of the Langerhans' islets. The estrogen receptor (ER) and PR status has been used for over 20 years as a predictor of breast carcinoma responsiveness to endocrine therapy and as a prognostic indicator for early recurrence.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 1-200) of human PGR (exact sequence is proprietary)

    Isotyp

    IgG, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    Progesterone Receptor (PGR)

    Andere Bezeichnung

    Progesterone Receptor

    Hintergrund

    NR3C3, Nuclear receptor subfamily 3 group C member 3, PGR, PR, PRA, PRB, Progesterone receptor form A, Progesterone receptor form B

    Human breast carcinoma.

    Molekulargewicht

    PR-A (81kDa) and PR-B (116kDa).

    Gen-ID

    5241, 2905

    UniProt

    P06401

    Pathways

    Nuclear Receptor Transcription Pathway, Intracellular Steroid Hormone Receptor Signaling Pathway, Steroid Hormone Mediated Signaling Pathway, Smooth Muscle Cell Migration
Sie sind hier:
Chat with us!